Form 8-K - Current report:
SEC Accession No. 0000014272-20-000075
Filing Date
2020-02-06
Accepted
2020-02-06 08:20:13
Documents
17
Period of Report
2020-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q42019earningsrelease8.htm   iXBRL 8-K 66434
2 PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY DATED FEBRUARY 6, 2020 q42019ex991.htm EX-99.1 657962
3 CERTAIN SUPPLEMENTAL INFORMATION q42019ex992.htm EX-99.2 3011647
9 bmslogoa06.jpg GRAPHIC 79779
  Complete submission text file 0000014272-20-000075.txt   4169916

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20200124.xsd EX-101.SCH 6132
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20200124_cal.xml EX-101.CAL 750
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20200124_def.xml EX-101.DEF 9143
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20200124_lab.xml EX-101.LAB 39730
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20200124_pre.xml EX-101.PRE 19601
12 EXTRACTED XBRL INSTANCE DOCUMENT q42019earningsrelease8_htm.xml XML 11031
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 20581021
SIC: 2834 Pharmaceutical Preparations